Enrichment of invariant natural killer T cells in the bone marrow of visceral leishmaniasis patients

Parasite Immunology

Volumn 33, Issue 12, 2011, Pages 688-691

  Rai, A K ^a   Thakur, C P ^b   Seth, T ^a   Mitra, D K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Balaji Utthan Sansthan   (India)

Author keywords

CD1d; Invariant NKT; Leishmania donovani; Lipophosphoglycan; Visceral leishmaniasis

Indexed keywords

ADULT; ARTICLE; BONE MARROW; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOLIPIDS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PHOSPHOLIPIDS; YOUNG ADULT;

LEISHMANIA DONOVANI;

EID: 81255147217     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01328.x     Document Type: Article

References (16)

1. Bendelac A, Savage PB & Teyton L. The biology of NKT Cells. Annu Rev Immunol 2007; 25: 297-336.
2. Kronenberg M. Toward an understanding of NKT cell biology: progress and Paradoxes. Annu Rev Immunol 2005; 26: 877-900.
3. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ & Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004; 4: 231-237.
4. Mattner J, DeBord KL, Ismail N, et al. Both exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434: 525-529.
5. Benlagha K, Kyin T, Beavis A, Teyton L & Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002; 296: 553-555.
6. Kobayashi E, Motoki K, Uchida T, Fukushima H & Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 1995; 7: 529-534.
7. Kinjo Y, Wu D, Kim G, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434: 520-525.
8. Amprey JL, Im JS, Turco SJ, et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 2004; 200: 895-904.
9. Chulay JD & Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983; 32: 475-479.
10. Beattie L, Svensson M, Bune A, et al. Leishmania donovani-induced expression of signal regulatory protein a on Kupffer cells enhances hepatic invariant NKT-cell activation. Eur J Immunol 2010; 40: 117-123.
11. Stanley AC, Zhou Y, Amante FH, et al. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog 2008; 4: e1000028. doi:.
12. Hogan AE, O'Reilly V, Dunne MR, et al. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide. Clin Immunol 2011; 140: 196-207.
13. Moreira-Teixeira L, Resende M, Coffre M, et al. Proinflammatory environment dictates the IL-17 producing capacity of human invariant NKT cells. J Immunol 2011; 186: 5758-5765.
14. Rai AK, Thakur CP, Seth T & Mitra DK. Early activated Th-1 type and dominantly diverse natural killer T (CD3 + CD161+ Vα24-) cells in bone marrow among visceral leishmaniasis patients. Int J Parasitol 2011, 41: 1069-1077.
15. Behar SM & Cardell S. Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions. Semin Immunol 2000; 12: 551-560.
16. Chen H & Paul WE. Cultured NK1.1+CD4+T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 1997; 159: 2240-2249.